Pharmaceutical combination containing capsid protein inhibitor and nucleoside analog

(canceled)

(canceled)

A kit for use in treating hepatitis B virus infection comprising:

• (a) a first pharmaceutical composition comprising a compound of formula I or a pharmaceutically acceptable salt thereof as an active ingredient;
• and (b) a second pharmaceutical composition comprising a reverse transcriptase inhibitor or a pharmaceutically acceptable prodrug thereof or a pharmaceutically acceptable salt thereof or a solvate thereof as an active ingredient;
• and optionally (c) instructions for use of the compound of formula I or the pharmaceutically acceptable salt thereof in combination with the reverse transcriptase inhibitor or the pharmaceutically acceptable prodrug thereof or the pharmaceutically acceptable salt thereof or the solvate thereof,